Marta RF - Search Results

1

Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count.

Lev PR, Grodzielski M, Goette NP, Glembotsky AC, Espasandin YR, Pierdominici MS, Contrufo G, Montero VS, Ferrari L, Molinas FC, Heller PG, Marta RF. Lev PR, et al. Among authors: marta rf. Br J Haematol. 2014 Jun;165(6):854-64. doi: 10.1111/bjh.12832. Epub 2014 Mar 27. Br J Haematol. 2014. PMID: 24673454 Free article.

2

Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever.

Heller MV, Marta RF, Sturk A, Maiztegui JI, Hack CE, Cate JW, Molinas FC. Heller MV, et al. Among authors: marta rf. Thromb Haemost. 1995 Mar;73(3):368-73. Thromb Haemost. 1995. PMID: 7667817

3

Further studies on the plasma inhibitor of platelet activation in Argentine hemorrhagic fever.

Marta RF, Heller MV, Maiztegui JI, Molinas FC. Marta RF, et al. Thromb Haemost. 1993 May 3;69(5):526-7. Thromb Haemost. 1993. PMID: 8322277 No abstract available.

4

Proinflammatory cytokines and elastase-alpha-1-antitrypsin in Argentine hemorrhagic fever.

Marta RF, Montero VS, Hack CE, Sturk A, Maiztegui JI, Molinas FC. Marta RF, et al. Am J Trop Med Hyg. 1999 Jan;60(1):85-9. doi: 10.4269/ajtmh.1999.60.85. Am J Trop Med Hyg. 1999. PMID: 9988328

5

Relationship between hematopoietic growth factors levels and hematological parameters in Argentine hemorrhagic fever.

Marta RF, Enria D, Molinas FC. Marta RF, et al. Am J Hematol. 2000 May;64(1):1-6. doi: 10.1002/(sici)1096-8652(200005)64:1<1::aid-ajh1>3.0.co;2-f. Am J Hematol. 2000. PMID: 10815780 Free article.

6

Effectiveness of anagrelide in the treatment of symptomatic patients with essential thrombocythemia.

Laguna MS, Kornblihtt LI, Marta RF, Michiels JJ, Molinas FC. Laguna MS, et al. Among authors: marta rf. Clin Appl Thromb Hemost. 2000 Jul;6(3):157-61. doi: 10.1177/107602960000600307. Clin Appl Thromb Hemost. 2000. PMID: 10898276 Free article. Clinical Trial.

7

[Thromboxane B2 and platelet derived growth factor in essential thrombocythemia treated with anagrelide].

Laguna MS, Kornblihtt LI, Marta RF, Molinas FC. Laguna MS, et al. Among authors: marta rf. Medicina (B Aires). 2000;60(4):448-52. Medicina (B Aires). 2000. PMID: 11188949 Spanish.

8

Variation of PDGF, TGFbeta, and bFGF levels in essential thrombocythemia patients treated with anagrelide.

Lev PR, Marta RF, Vassallu P, Molinas FC. Lev PR, et al. Among authors: marta rf. Am J Hematol. 2002 Jun;70(2):85-91. doi: 10.1002/ajh.10091. Am J Hematol. 2002. PMID: 12111780 Free article. Clinical Trial.

9

Increased levels of plasma interleukin-6 soluble receptor in patients with essential thrombocythemia.

Marta R, Goette N, Lev P, Heller P, Kornblihtt L, Vassallú P, Glembotsky A, Pirola C, Molinas F. Marta R, et al. Haematologica. 2004 Jun;89(6):657-63. Haematologica. 2004. PMID: 15194532

10

Normal platelets possess the soluble form of IL-6 receptor.

Marta RF, Goette NP, Lev PR, Chazarreta CD, Pirola CJ, Molinas FC. Marta RF, et al. Cytokine. 2005 Jan 7;29(1):13-7. doi: 10.1016/j.cyto.2004.09.003. Cytokine. 2005. PMID: 15579373

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters